THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 138 filers reported holding THERAPEUTICSMD INC in Q1 2017. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $86,000 | +53.6% | 33,000 | +184.5% | 0.04% | +50.0% |
Q1 2019 | $56,000 | -27.3% | 11,600 | -0.9% | 0.02% | -11.1% |
Q3 2018 | $77,000 | -88.5% | 11,700 | -89.5% | 0.03% | -79.2% |
Q4 2017 | $671,000 | +69.0% | 111,166 | +61.6% | 0.13% | +293.9% |
Q4 2016 | $397,000 | -57.4% | 68,785 | -49.7% | 0.03% | -62.9% |
Q3 2016 | $931,000 | +106.0% | 136,685 | +157.2% | 0.09% | +43.5% |
Q2 2016 | $452,000 | -20.1% | 53,149 | -39.9% | 0.06% | -19.5% |
Q1 2016 | $566,000 | +20.7% | 88,401 | +95.5% | 0.08% | +28.3% |
Q4 2015 | $469,000 | +47.5% | 45,228 | -16.6% | 0.06% | +20.0% |
Q3 2015 | $318,000 | +205.8% | 54,209 | +308.0% | 0.05% | +194.1% |
Q2 2015 | $104,000 | -7.1% | 13,288 | -27.9% | 0.02% | +21.4% |
Q1 2015 | $112,000 | -76.6% | 18,441 | -82.8% | 0.01% | -79.4% |
Q4 2014 | $478,000 | +154.3% | 107,341 | +165.0% | 0.07% | +119.4% |
Q3 2014 | $188,000 | +72.5% | 40,500 | +134.4% | 0.03% | -3.1% |
Q1 2014 | $109,000 | +47.3% | 17,281 | +21.0% | 0.03% | +3.2% |
Q4 2013 | $74,000 | – | 14,281 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
1492 Capital Management LLC | 387,529 | $2,341,000 | 1.83% |
SANDERS MORRIS HARRIS LLC | 521,500 | $3,150,000 | 1.33% |
Newtyn Management, LLC | 1,250,000 | $7,550,000 | 1.15% |
ARDSLEY ADVISORY PARTNERS LP | 1,050,000 | $6,342,000 | 0.77% |
NEXTHERA CAPITAL LP | 528,351 | $3,191,000 | 0.59% |
MORGENS WATERFALL VINTIADIS & CO INC | 112,000 | $676,000 | 0.53% |
Capital Impact Advisors, LLC | 200,707 | $1,212,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 479,980 | $2,899,000 | 0.34% |
Rock Springs Capital Management LP | 1,175,000 | $7,097,000 | 0.32% |
QCM Cayman, Ltd. | 11,493 | $69,000 | 0.29% |